BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 394726)

  • 1. A tribute to Dr. Werner Bandel: his contributions to the development of Cuprophan membranes. From packaging films to hemodialysis and hemofiltration.
    Artif Organs; 1979 Nov; 3(4):329-31. PubMed ID: 394726
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of the AN69-S (Biospal) in conventional hemodialysis (HD) and in biofiltration (BF).
    Pisani E; Axia M; Morrone A; Carollo G
    Int J Artif Organs; 1986 Dec; 9 Suppl 3():75-7. PubMed ID: 3557679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial dialysis membranes: from concept to large scale production.
    Vienken J; Diamantoglou M; Henne W; Nederlof B
    Am J Nephrol; 1999; 19(2):355-62. PubMed ID: 10213843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One of the pioneers of dialysis membranes, Werner Henne, passes away.
    Vienken J
    Artif Organs; 2008 Jun; 32(6):423-4. PubMed ID: 18522552
    [No Abstract]   [Full Text] [Related]  

  • 5. Biofiltration: an effective and simple method to reduce dialysis time.
    Mingardi G; Massazza M; Viganò G; Mecca G
    Int J Artif Organs; 1986 Dec; 9 Suppl 3():133-6. PubMed ID: 3557661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of heparinized Cuprophan hemodialysis membranes.
    Hinrichs WL; ten Hoopen HW; Engbers GH; Feijen J
    J Biomed Mater Res; 1997 Jun; 35(4):443-50. PubMed ID: 9189822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells.
    Linnenweber S; Lonnemann G
    Kidney Int Suppl; 2001 Feb; 78():S282-5. PubMed ID: 11169027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Continuous arteriovenous hemodialysis with cuprophan membrane].
    Cotera A; Lorca E; Saffie A
    Rev Med Chil; 1991 Aug; 119(8):939-40. PubMed ID: 1844779
    [No Abstract]   [Full Text] [Related]  

  • 9. The next generation of dialysis membranes--barriers or pathways?
    Streicher E; Schneider H
    Contrib Nephrol; 1985; 44():127-36. PubMed ID: 3987283
    [No Abstract]   [Full Text] [Related]  

  • 10. An exact analysis for a solute transport, due to simultaneous dialysis and ultrafiltration, in a hollow-fibre artificial kidney.
    Tyagi VP; Abbas M
    Bull Math Biol; 1987; 49(6):697-717. PubMed ID: 3442712
    [No Abstract]   [Full Text] [Related]  

  • 11. Limulus amebocyte lysate reactivity, complement activation, and patients' symptoms. Comparison of dialyzer membranes.
    Moss AH; Hamrick RM; Shen SH
    ASAIO Trans; 1989; 35(4):812-5. PubMed ID: 2611049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protamine-coated Cuprophan. A potential nonthrombogenic hemodialysis membrane with improved blood compatibility.
    Yang VC; Fu YY; Kim JS
    ASAIO Trans; 1991; 37(3):M229-32. PubMed ID: 1751122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short hemodialysis.
    von Albertini B; Bosch JP
    Am J Nephrol; 1991; 11(3):169-73. PubMed ID: 1962662
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement activation during hemodialysis. Comparison of polysulfone and cuprophan membranes.
    Stannat S; Bahlmann J; Kiessling D; Koch KM; Deicher H; Peter HH
    Contrib Nephrol; 1985; 46():102-8. PubMed ID: 3874042
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anaphylactic reactions during hemodialysis: responsibility of the dialysis membrane (cuprophane)].
    Kessler M; Maurice F; Moneret-Vautrin DA; Hurault de Ligny B; Caraman PL; Huriet C
    Nephrologie; 1984; 5(3):119-22. PubMed ID: 6493430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous hemofiltration/hemodialysis: an effective alternative to hemofiltration and conventional hemodialysis in the treatment of uremic patients.
    Leber HW; Wizemann V; Goubeaud G; Rawer P; Schütterle G
    Clin Nephrol; 1978 Mar; 9(3):115-21. PubMed ID: 639371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
    Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
    Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in leukocyte counts using a cellulose acetate membrane (FB-T) during hemodialysis. A comparison with a cuprophane membrane].
    Pak K; Kobira S; Tomoyoshi T; Nishimura N
    Hinyokika Kiyo; 1986 Sep; 32(9):1231-5. PubMed ID: 3812143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research on dialyzers with improved biocompatibility.
    van der Steen A
    Clin Nephrol; 1986; 26 Suppl 1():S39-42. PubMed ID: 3829466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorbent membranes used in a conventional dialyzer format. In vitro and clinical evaluation.
    Gurland HJ; Fernandez JC; Samtleben W; Castro LA
    Artif Organs; 1978 Nov; 2(4):372-4. PubMed ID: 743008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.